PERICARDIAL MESOTHELIOMA MALIGNANT

PERICARDIAL MESOTHELIOMA MALIGNANT was reported 9 times

PERICARDIAL MESOTHELIOMA MALIGNANT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkaloid [EPC] 4 0.0002
1 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
3 Leukocyte Growth Factor [EPC] 1 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
5 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
6 Platinum-based Drug [EPC] 1 0.0000
7 Corticosteroid [EPC] 3 0.0000
8 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000